|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.86 HKD | +0.47% |
|
+7.53% | +35.51% |
| Apr. 09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
| Apr. 01 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 3,209 million compared to CNY 1,293.31 million a year ago. Net income was CNY 1,029.5 million compared to net loss of CNY 32.8 million a year ago.
Basic earnings per share from continuing operations was CNY 1.17 compared to basic loss per share from continuing operations of CNY 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.51% | 1.44B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. 
